Accord Logo

Intended for UK patients and members of the public

Apixaban Accord 2.5mg film-coated tablets

Apixaban Film-coated Tablets

Active Ingredients

Product Documentation

  • View RMM (RMM- Apixaban Patient Alert Card)

    Last updated on this site: 04 Sep 2025

    Description of update: To update the Patient Alert Card in line with the reference product (Eliquis 2.5 mg/ 5 mg film-coated tablets; PLGB number: PLGB 54213/0001-0002; MAH: Bristol-Myers Squibb/Pfizer EEIG, Ireland).

    Date of approval: 22/08/2025

    View change history

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Apixaban Accord 2.5mg film-coated tablets

PL Number:
PLGB 20075/1405
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

Contact Us Report a side effect or product complaint

View product information as a: